ABSTRACT
Congenital splenic cysts are rare entities wich are not frequently diagnosed in prenatal sonographies and there is only a few literature wich report these medical cases. The aim of this article is to introduce this sonographic discovery and study whether there are impacts for the newborn, association with cormosomopathy or fetal pathology. We describe two medical cases of fetal splenic cysts wich were diagnosed in our service by ultrasonography at 29 and 32 weeks of gestation, their antenatal monitoring and postnatal evolution. Besides theses, it is made a review of this entity in medical literature, examination about the: etiology, prenatal diagnosis, prenatal and postnatal following and complications. In conclusion, the congenital splenic cyst has a good prognosis with an spontaneous postnatal resolution in the majority of the cases. No association was observed between cromosopathy or fetal pathology with the examined cases.
Subject(s)
Cysts/diagnostic imaging , Splenic Diseases/diagnostic imaging , Ultrasonography, Prenatal/methods , Adult , Cysts/congenital , Female , Fetal Diseases/diagnostic imaging , Fetal Diseases/pathology , Follow-Up Studies , Humans , Infant, Newborn , Male , Pregnancy , Prognosis , Splenic Diseases/congenitalABSTRACT
This international retrospective study of 593 Splenic Marginal Zone Lymphoma (SMZL) patients aimed to identify factors that determine treatment initiation and influence lymphoma-specific survival (LSS). Logistic regression was used to identify the factors associated with treatment. A Cox regression was used to analyse LSS in a derivation cohort of 366 patients. This produced a prognostic index (PI) and enabled the identification of three risk groups. The resulting stratification was validated in another cohort of 227 patients and compared with the Interguppo Italiano Linfomi (IIL) score in the group of 450 patients for whom all the required data were available using an extension of the net reclassification improvement. Haemoglobin concentration (Hb), extrahilar lymphadenopathy and hepatitis C virus status were associated with the initiation of treatment. Hb, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy were independently associated with LSS. Three risk groups with significantly different five-year LSS (94%, 78% and 69%, respectively) were identified. This stratification (named HPLL on the basis of determinant factors) had a better discriminative power than the IIL score. This system is useful for stratifying SMZL patients into risk groups and may help in the selection of risk-tailored treatment approaches.
Subject(s)
Hemoglobins/metabolism , L-Lactate Dehydrogenase/blood , Lymphoma, B-Cell, Marginal Zone , Splenic Neoplasms , Aged , Disease-Free Survival , Female , Humans , Lymphoma, B-Cell, Marginal Zone/blood , Lymphoma, B-Cell, Marginal Zone/mortality , Lymphoma, B-Cell, Marginal Zone/therapy , Male , Middle Aged , Platelet Count , Retrospective Studies , Risk Factors , Splenic Neoplasms/blood , Splenic Neoplasms/mortality , Splenic Neoplasms/therapy , Survival RateABSTRACT
An 80-year-old man was admitted to hospital with low-grade fever, weight loss, asthenia and anorexia. Physical examination revealed generalised ichthyosis with palmoplantar hyperkeratosis. CT scan showed retroperitoneal and inguinal lymph node enlargement. An inguinal lymph node biopsy revealed Hodgkin's disease (nodular-sclerosing subtype). The patient received chemotherapy, showing a clear improvement of both skin lesions and lymph nodes.
Subject(s)
Hodgkin Disease/diagnosis , Ichthyosis/diagnosis , Paraneoplastic Syndromes/diagnosis , Aged, 80 and over , Hodgkin Disease/drug therapy , Hodgkin Disease/pathology , Humans , Ichthyosis/pathology , Lymph Nodes/pathology , Male , Paraneoplastic Syndromes/pathologyABSTRACT
Primary ovarian Burkitt lymphoma (BL) is a rare neoplasm in adults. We report a 30-year-old woman diagnosed with primary bilateral ovarian BL. She presented features of a twisted ovarian cyst and underwent bilateral salpingo-oophorectomy. The histopathologic evaluation yielded the diagnosis of BL and subsequently she received chemoimmunotherapy with CODOX-M-IVAC plus rituximab (anti-CD20 monoclonal antibody).